摘要
目的：研究顽固性心力衰竭（CHF）的治疗是为了提高顽固性CHF的治疗水平. 方法：104例顽固性CHF入院后随机分为治疗组58例,对照组46例.两组均按现代医药治疗以利尿剂、扩血管（硝酸脂类）、β-阻断肾素血管激活药、转换酶抑制剂及抗醛固拮抗剂治疗.治疗组：运用丹红注射液和脑心通胶囊治疗;对照组：用生脉注射液和心脑康胶囊治疗.结果： 两组患者治疗前后BP、HR、胸腔比值、NYHA检查及分级改变,并随防观察1年,住院次数、天数结果P〈0.05,有显著性差异.一年后治疗组生存57例,占98.28%;死亡1例,占1.72%.对照组生存43例,占93.48%;死亡3例,占6.52%.结论：顽固性CHF治疗必须脑心同治、中西结合.丹红注射液和脑心通胶囊治疗顽固性CHF可提高治愈率和生存率.
Objective To study the refractory congestive heart failure（CHF） treatment is to increase the treatment level of this disease. Methods 104 patients with refractory CHF were randomly divided into experiment group（n= 58） receiving Danhong injection, Naoxintong capsule and control group（n=46） receiving Shengmai injecton, Xinnaokang capsule. Both groups were treated with diuretics, vasodilators （nitrates）, B-Receipt Blocker, renin--vascular activator, converting enzyme inhibitors and aldosterone antagonists. Results Blood pressure, heart rate,chest ratio and NYHA classification were observed before and after treatment, and follow-up observation of the frequency and days of hospitalization in one year. These indexex were significant changed（P〈0.05）. The experiment group after one year survived 57 cases accounting for 98.28% and 1 died accountig for 1. 72%, the control group survived 4：3 cases accounting for 93.48% and 3 died accounting for 6.52%. Conclusions The treatment methods of refractory CHF should treat the brain and heart at the same time and combine the chinese medeine. Danhong injection, Naoxintong capsule treatment can improve the cure rate and survival rate of refractory CHF.
关键词
顽固性CHF
丹红注射液
脑心通胶囊
脑心同治
refractory CHF
Danhong injection
Naoxintong capsule
Brain heart treatment
